WallStSmart

ASP Isotopes Inc. Common Stock (ASPI)vsBraskem SA Class A (BAK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Braskem SA Class A generates 247774% more annual revenue ($66.75B vs $26.93M). ASPI leads profitability with a 0.0% profit margin vs -13.7%. BAK earns a higher WallStSmart Score of 38/100 (F).

ASPI

Avoid

31

out of 100

Grade: F

Growth: 6.3Profit: 2.5Value: 6.7Quality: 6.0
Piotroski: 4/9Altman Z: -0.12

BAK

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.5Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 0.13
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ASPIUndervalued (+80.8%)

Margin of Safety

+80.8%

Fair Value

$29.49

Current Price

$6.71

$22.78 discount

UndervaluedFair: $29.49Overvalued

Intrinsic value data unavailable for BAK.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASPI2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
279.3%10/10

Revenue surging 279.3% year-over-year

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

BAK2 strengths · Avg: 10.0/10
EPS GrowthGrowth
107.2%10/10

Earnings expanding 107.2% YoY

Debt/EquityHealth
-4.3010/10

Conservative balance sheet, low leverage

Areas to Watch

ASPI4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$950.57M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-60.0%2/10

ROE of -60.0% — below average capital efficiency

BAK4 concerns · Avg: 2.5/10
Market CapQuality
$1.66B3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-549.0%2/10

ROE of -549.0% — below average capital efficiency

Revenue GrowthGrowth
-20.4%2/10

Revenue declined 20.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : ASPI

The strongest argument for ASPI centers on Revenue Growth, Price/Book. Revenue growth of 279.3% demonstrates continued momentum.

Bull Case : BAK

The strongest argument for BAK centers on EPS Growth, Debt/Equity. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bear Case : ASPI

The primary concerns for ASPI are EPS Growth, Market Cap, Profit Margin.

Bear Case : BAK

The primary concerns for BAK are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

ASPI profiles as a hypergrowth stock while BAK is a turnaround play — different risk/reward profiles.

ASPI carries more volatility with a beta of 3.27 — expect wider price swings.

ASPI is growing revenue faster at 279.3% — sustainability is the question.

ASPI generates stronger free cash flow (-24M), providing more financial flexibility.

Bottom Line

BAK scores higher overall (38/100 vs 31/100). ASPI offers better value entry with a 80.8% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ASP Isotopes Inc. Common Stock

BASIC MATERIALS · CHEMICALS · USA

Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.

Braskem SA Class A

BASIC MATERIALS · CHEMICALS · USA

Braskem SA produces and markets thermoplastic resins. The company is headquartered in Camaari, Brazil.

Want to dig deeper into these stocks?